Actively Recruiting
A Long-term Observational Study Evaluating the Presentation and Management of Acute Respiratory Tract Infections in Primary Care Across Europe
Led by European Clinical Research Alliance for Infectious Diseases (ECRAID) · Updated on 2026-04-14
2000
Participants Needed
3
Research Sites
122 weeks
Total Duration
On this page
Sponsors
E
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Lead Sponsor
U
UMC Utrecht
Collaborating Sponsor
AI-Summary
What this Trial Is About
Acute respiratory infection (ARI) is the commonest reason for consulting in community care. Furthermore, new and re-emerging pathogens are often first noticed in primary care (PC). The POS-ARI-PC study is a long-term study, with the aim of describing the nature of ARI in adults and children presenting to PC across Europe. The POS-ARI-PC study will provide critically important data on the presentation and management of ARI, and build a research-ready infrastructure for studies related to the treatment, diagnosis, and prevention of ARI in primary care settings. Additional observational studies will be embedded and use the infrastructure developed in POS-ARI-PC.
CONDITIONS
Official Title
A Long-term Observational Study Evaluating the Presentation and Management of Acute Respiratory Tract Infections in Primary Care Across Europe
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients of any age consulting with a participating healthcare facility via telephone, video, or face-to-face
- Symptoms suggestive of acute lower respiratory tract infection with cough as the main symptom lasting less than 28 days
- Symptoms suggestive of acute upper respiratory tract infection with sore throat and/or runny nose lasting less than 14 days
- Patients suspected of having COVID-19, influenza, or RSV
- Willing and able to provide informed consent and comply with study procedures (for POS-ARI-PC CORE)
You will not qualify if you...
- Patients who have withdrawn consent for anonymous data collection by their healthcare facility
- Patients unable to comply with study procedures due to language barriers without assistance, serious psychiatric disorders, or terminal illness
- Symptoms that are likely non-infectious in origin
- Patients requiring hospital admission on the day of inclusion (except in POS-ARI-PC-001 if timing allows)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Universiteit Antwerpen
Antwerp, Belgium
Actively Recruiting
2
Centre Hospitalier Universitaire de Limoges
Limoges, France
Actively Recruiting
3
University of Oxford
Oxford, United Kingdom
Actively Recruiting
Research Team
C
Christopher Butler
CONTACT
N
Nguyen Tran
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here